We are live on !
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow % of AUM
Cap. Flow %
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
Dycom Industries
DY
$7.65B
| $396K | 0.01% |
1,171
| – | – |
2025 Q4
1 quarter
|
|
1002
Super Micro Computer
SMCI
$20.8B
| $395K | 0.01% |
13,511
| – | – |
2025 Q2
3 quarters
|
|
1003
Allison Transmission
ALSN
$9.23B
| $394K | 0.01% |
4,030
| – | – |
2025 Q4
1 quarter
|
|
1004
Nomura Holdings
NMR
$27B
| $394K | 0.01% |
46,973
| – | – |
2025 Q2
3 quarters
|
|
1005
Box
BOX
$5.43B
| $394K | 0.01% |
13,163
| – | – |
2024 Q3
6 quarters
|
|
1006
New Jersey Resources
NJR
$5.3B
| $393K | 0.01% |
8,532
| – | – |
2025 Q2
3 quarters
|
|
1007
Carpenter Technology
CRS
$18.7B
| $393K | 0.01% |
1,248
| – | – |
2025 Q2
3 quarters
|
|
1008
Advanced Energy
AEIS
$9.5B
| $392K | 0.01% |
1,874
| – | – |
2025 Q3
2 quarters
|
|
1009
Grayscale Ethereum Staking Mini ETF Shares
ETH
$2.02B
| $392K | 0.01% |
13,967
| – | – |
2025 Q4
1 quarter
|
|
1010
BrightSpring Health Services
BTSG
$12B
| $392K | 0.01% |
10,457
| – | – |
2025 Q3
2 quarters
|
|
1011
Selective Insurance
SIGI
$5.31B
| $390K | 0.01% |
4,667
| – | – |
2025 Q3
2 quarters
|
|
1012
Griffon
GFF
$4.21B
| $390K | 0.01% |
5,292
| – | – |
2025 Q2
3 quarters
|
|
1013
Ralph Lauren
RL
$23B
| $388K | 0.01% |
1,096
| – | – |
2025 Q2
3 quarters
|
|
1014
Saic
SAIC
$5.58B
| $385K | 0.01% |
3,829
| – | – |
2025 Q2
3 quarters
|
|
1015
United Therapeutics
UTHR
$22.9B
| $385K | 0.01% |
790
| – | – |
2025 Q4
1 quarter
|
|
1016
Commault Systems
CVLT
$6.18B
| $384K | 0.01% |
3,065
| – | – |
2023 Q4
9 quarters
|
|
1017
W.P. Carey
WPC
$14.8B
| $384K | 0.01% |
5,961
| – | – |
2025 Q4
1 quarter
|
|
1018
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$6.08B
| $383K | 0.01% |
7,263
| – | – |
2025 Q4
1 quarter
|
|
1019
Tower Semiconductor
TSEM
$22.1B
| $383K | 0.01% |
3,265
| – | – |
2025 Q4
1 quarter
|
|
1020
Woodside Energy
WDS
$44.9B
| $382K | 0.01% |
24,532
| – | – |
2024 Q4
5 quarters
|
|
1021
Donaldson
DCI
$10.2B
| $382K | 0.01% |
4,313
| – | – |
2025 Q3
2 quarters
|
|
1022
Arrow Electronics
ARW
$10.9B
| $382K | 0.01% |
3,466
| – | – |
2024 Q4
5 quarters
|
|
1023
Viatris
VTRS
$21.4B
| $382K | 0.01% |
30,669
| – | – |
2024 Q4
5 quarters
|
|
1024
Centene
CNC
$34.2B
| $380K | 0.01% |
9,231
| – | – |
2024 Q3
6 quarters
|
|
1025
DELISTED
Hologic
HOLX
| $380K | 0.01% |
5,096
| – | – |
2025 Q3
2 quarters
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.